Pinealon and Crystagen in a 28-rower study
V. Kh. Khavinson et al. · 2018 · Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182
Indexed 2026-11-09.
Related evidence maps: Sports performance ↗
Reported findings and study design
The monograph reports changes in oxidative biomarkers, alongside little change in several blood counts. It does not establish individual effects of Pinealon and Crystagen.
The authors describe stratified randomization and clinical, laboratory and oxidative-status measurements. Active supplement selection was individualized.
Dose, route and schedule
One oral capsule twice a day during meals for ten days in the active group. Individual capsule payload and allocation by preparation are not recoverable for each endpoint.
Protocol source ↗ · Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Hemoglobin | 136.1 → 134.4 g/L active; 137.0 → 141.6 g/L control | Selected Table 6.6 means. |
| Leukocytes | 5.2 → 5.1 vs 5.9 → 5.8 ×10⁹/L | Active versus ordinary-training group, Table 6.6. |
| Oxidative markers | Authors described lower lipid-peroxidation products | Biomarker results are separate from timed rowing. |
Usual training was the comparator. Heterogeneous formulations and small groups limit attribution. Do not merge with Emirova’s older cytamin series.
Source for the extracted data ↗ · Checked 2026-11-09
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Usual training was the comparator. Heterogeneous formulations and small groups limit attribution. Do not merge with Emirova’s older cytamin series.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182
Review depth: Reported methods, results and evidence limitations
Source access and review scope
Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182
Citation and original source
Original source: V. Kh. Khavinson et al.. Pinealon and Crystagen in a 28-rower study Molecular and Cellular Mechanisms of Peptidergic Regulation of Brain Functions, Chapter 6.1.2, pp. 168–182 2018.
Molekul research summary: https://molekul.io/research/khavinson-cytamins-rowers-2018. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pinealon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Crystagen
A product named in the originating-institute clinical-report collection. Experimental sequence, marketed formulation and clinical preparation must be checked separately.